Fast Access to High Microplate Sample Integrity
Porvair Sciences has launched a new online service (www.microplateseals.co.uk)
Available in a wide choice of colour-coded designs, Porvair microplate thermal seals are available optimized for use with all brands of assay plates. These easy-to-use thermal seals work with all commercially available heat sealers that take pre-cut strip seals. They are printed in five different colours and marked “This way up” to ensure easy selection of the right gauge of seal and correct positioning on the microplate. Seals are compatible with most heat sealers.
Each aluminium foil microplate seal is spray-coated with an acrylic varnish that is solvent resistant and will not contaminate your samples. It also makes an excellent permanent weld seal to polystyrene and polypropylene microplates. The easily peelable foil is actually a laminate of aluminium and polyester that provides durability and strength, while remaining easy to remove. A sample pack of foils is available on request from Porvair Sciences to enable you to determine the optimum seal for your application.
Porvair colour-coded optically clear seals are available in two gauges, both printed black “This way up” for ease of use. The thinner gauge gives the best optical results and is easily removed. The thicker material, while remaining clear after heat sealing, is optimised for long-term cold storage applications down to -20 °C.
For further information please contact Porvair Sciences now on +44 1372 824 290 or email [email protected]
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases.
-
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Dr Reddy's to launch generic semaglutide in India
Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a... -
News Frontier Biotech and GSK Forge RNA Therapy Partnership
Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...